You are here

Home / Resources / Key Material
Export 1049 results:
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 
S
Saslaw, S., & Carlisle H. N. (1966).  Aerosol infection of monkeys with Rickettsia rickettsii. Bacteriological Reviews. 30, 3.
Saslaw, S., Eigelsbach H. T., Prior J. A., Wilson H. E., & Carhart S. (1961).  Tularemia vaccine study. II. Respiratory challenge. Arch Intern Med. 702-714.
Saslaw, S.., & Carlisle H.. N. (1966).  Aerosol Infection of Monkeys with Rickettsia Rickettsi. Bacteriological Reviews. 30, 636-644.
Sapkota, A., & Sapkota AR. (2008).  Aquaculture practices and potential human health risks: Current knowledge and future priorities.
Sammons, L. S., Kenyon R. H., & Pedersen C. E. (1976).  Effect of vaccination schedule on immune response of Macaca mulatta to cell culture-grown Rocky Mountain spotted fever vaccine. Journal of Clinical Microbiology. 4, 3.
Salvador, RM. (2011).  Deteccao De Quantificacao de enterovirus em lodo de esgoto proveniente de estacoes de tratamento de esgotos com potencial uso na agrictultura do esado de sao paulo.
Sack, R. B., Siddique A. K., Longini, Jr I. M., Nizam A., Yunus M., Islam M. S., et al. (2003).  A 4-year study of the epidemiology of Vibrio cholerae in four rural areas of Bangladesh. Journal of Infectious Diseases. 187,
Sack, DA., & Sack RB. (2004).  Seminar: Cholera.
Sabino, R., Veríssimo C., Cunha M. Ana, Wergikoski B., Ferreira F. C., Rodrigues R., et al. (2011).  Pathogenic fungi: an unacknowledged risk at coastal resorts? New insights on microbiological sand quality in Portugal. Marine pollution bulletin. 62, 1506–1511.
Sabin, A.. B. (1955).  Behaviour Of Chimpanzee-Avirulent Poliomyelitis Viruses In Experimentally Infected Human Volunteers. The British Medical Journal. 2, 160-162.
Sabin, A. B. (1955).  Behavior of chimpanzee avirulent poliomyelitis viruses in experimentally infected human volunteers. The American journal of the medical sciences. 230, 1.
R
Ryan, KJ., & Ray CG. (2004).  Sherris Medical Microbiology: An Introduction to Infectious Disease.
Ryan, M., Gurian P., Haas C., Rose J., & Duzinski P. (2013).  Acceptable microbial risk: Cost-benefit analysis of a boil water order for Cryptosporidium. Journal of the American Water Works Association.
Ryan, M., Gurian P., Haas C., Rose J., & Duzinski P. (2013).  Acceptable microbial risk: Cost-benefit analysis of a boil water order for Cryptosporidium. Journal of the American Water Works Association.
Russell-Lodrigue, K.. E., Zhang G.. Q., McMurray D.. N., & Samuel J.. E. (2006).  Clinical and Pathologic Changes in a Guinea Pig Aerosol Challenge Model of Acute Q Fever. Infection and Immunity. 74, 11.
Royal Netherlands Meteorological Institute, (2010).  KNMI.
Roush, S. W., Baldy L. M., & Hall M. Ann Kirkco (2013).  Measles. VPD Surveillance Manual. 2015,
Rosete, D. P., Manjarrez M. Eugenia, & Barrón B. L. (2008).  Adenoviruses C in non-hospitalized Mexican children older than five years of age with acute respiratory infection. Memorias do Instituto Oswaldo Cruz. 103, 195–200.
Roser, DJ. (2015).  Dose–response algorithms for water-borne Pseudomonas aeruginosa folliculitis.
Rosenberry, B. (2002).  World shrimp farming 2002.
Rose, J. B. (2000).  Future health assessment and risk-management integration for infectious diseases and biological weapons for deployed US forces. Strategies to Protect the Health of Deployed: Assessing Health Risks Deployed US Forces. 59–112.
Rose, JB., Haas CN., & Regli S. (1991).  Risk assessment and control of waterborne giardiasis.. American Journal of Public Health. 81(6), 709–713.
Rose, J.. B., & Haas C.. N. (1999).  A risk assessment framework for the evaluation of skin infections and the potential impact of antibacterial soap washing. American Journal of Infection Control. 27, S26-S33.
Rose, J. B., & Haas C. N. (1999).  A risk assessment framework for the evaluation of skin infections and the potential impact of antibacterial soap washing. American Journal of Infection Control. 27, 26-33.
Roller, K. (1999).  Experimental Staph Vaccine Broadly Protective in Animal Studies. National Institute of Allergy and Infectious Diseases.